Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat

Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation

(2011) Johan Fernø et al.   PLoS One

Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective

(2010) Sam Virtue et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance

(2010) P. J. F. Martins et al.   DIABETES

Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis

(2010) V L Albaugh et al.   MOLECULAR PSYCHIATRY

A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model

(2010) Heidi N. Boyda et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

(2010) Christine Rummel-Kluge et al.   SCHIZOPHRENIA RESEARCH

Hypothalamic lipotoxicity and the metabolic syndrome

(2009) Pablo B. Martínez de Morentin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Dyslipidemia Independent of Body Mass in Antipsychotic-Treated Patients Under Real-Life Conditions

(2009) Astrid B. Birkenaes et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

(2009) Gavin P Reynolds et al.   PHARMACOLOGY & THERAPEUTICS

Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model

(2009) Araba F. Chintoh et al.   SCHIZOPHRENIA RESEARCH

Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: Implications for glucose metabolism and food choice behaviour

(2009) Greg C. Smith et al.   SCHIZOPHRENIA RESEARCH

Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat

(2008) G. C. Smith et al.   DIABETOLOGIA

The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: Comparison with aripiprazole, ziprasidone, bifeprunox and F15063

(2008) Marie-Bernadette Assié et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

SREBPs: physiology and pathophysiology of the SREBP family

(2008) Hitoshi Shimano   FEBS Journal

Olanzapine-induced Elevation of Serum Triglyceride Levels in a Normal Weight Patient with Schizophrenia

(2008) Takahiko Nagamine   INTERNAL MEDICINE

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

The Role of Thermogenesis in Antipsychotic Drug-induced Weight Gain

(2008) Aneta Stefanidis et al.   Obesity

Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver

(2008) Johan Fernø et al.   PSYCHOPHARMACOLOGY

It's Not How Fat You Are, It's What You Do with It That Counts

(2008) Samuel Virtue et al.   PLOS BIOLOGY